盈康生命 (300143)

INKON Life Technology Co., Ltd.

ASZ

Tags

AI HealthcareDeepSeekLong-Term Non-Dividend PayersArtificial Intelligence (AI)Elderly Care ConceptVenture Capital ConceptMedical ServicesMedical Aesthetics ConceptPharmaceuticals and HealthcareExoskeletonSmart HealthcareIntelligent MachinesPrivate HospitalsInternet of Things (IoT)Margin Trading and Securities LendingChiNext 200 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 74945.16
  • Circulating A-Shares(W): 64136.32
  • Earnings Per Share(RMB): 0.1168
  • Net Assets Per Share(RMB): 3.3687
  • Operating Revenue(W RMB): 135776.26
  • Total Profit(W RMB): 12835.53
  • Net Profit Attributable to Parent(W RMB): 8683.89
  • Net Profit Growth Rate(%): 5.20
  • Weighted Return on Equity(%): 3.5000
  • Operating Cash Flow Per Share(RMB): 0.3310
  • Undistributed Profit Per Share(RMB): 0.1956
  • Capital Reserve Per Share(RMB): 2.3131

2. Main Business

The main business covers:

  • Oncology-focused medical services
  • R&D of key scenario and key equipment medical devices
  • Innovation of key scenario and key equipment medical devices
  • Services for key scenario and key equipment medical devices

3. Company Basic Information

  • Company Name: INKON Life Technology Co., Ltd.
  • Listing Date: 2010-12-09
  • Industry: Medical & Pharmaceutical - Medical Services
  • Address: 17F, INKON Life Building, No.1 Haier Road, Laoshan District, Qingdao City, Shandong Province
  • Website: www.inkonlife.com
  • Company Profile: The company's predecessor was Dongguan Xinghe Industrial Co., Ltd., established on August 6, 1998, and renamed Dongguan Xinghe Biotechnology Co., Ltd. on July 4, 2003. The company was established as a joint-stock company through overall transformation, based on the net assets of Xinghe Co., Ltd. as of May 31, 2008, amounting to 72,652,417.67 yuan, converted into shares at a ratio of 1:0.62. After the change, the company's total share capital was 45 million shares, with a par value of 1 yuan per share, and the remaining net assets of 27,652,417.67 yuan after share conversion were included in capital reserve. On August 15, 2008, Tianjian Zhengxin issued the Zhonghe Zhengxin Yan Zi (2008) No. 7-013 "Capital Verification Report" for the company, verifying the capital contribution. The company completed the industrial and commercial registration procedures at the Dongguan Administration for Industry and Commerce of Guangdong Province on September 17, 2008, obtained the business license, with the industrial and commercial registration number 441900000178999, and registered capital of 45 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Qingdao INKON Medical Investment Co., Ltd. General Legal Person 26388.49 41.14
2 Qingdao Haichuangzhi Management Consulting Enterprise (Limited Partnership) General Legal Person 1110.45 1.73
3 China Foreign Economic and Trade Trust Co., Ltd. - Foreign Trade Trust - Ruijun Wenxiang Private Securities Investment Fund Private Securities Investment Fund 1025.31 1.60
4 Galaxy Kangle Stock Securities Investment Fund Class A Fund 81.32 0.13

5. Concept Sectors

  • Internet of Things
  • Venture Capital Concept
  • Pension Concept
  • Private Hospitals
  • Intelligent Machines
  • Intelligent Healthcare
  • Artificial Intelligence
  • Medical Aesthetics Concept
  • DeepSeek
  • AI Healthcare
  • Exoskeleton
  • Margin Trading & Securities Lending
  • Long-term No Dividend
  • Chuangye 200 Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information